AKT1 and cancer: A disintegrin‐like and metalloprotease with thrombospondin type 1 motif 9 (ADAMTS9) encodes a zinc metalloprotease that has been shown to function as a tumour suppressor in other cancer models leading to downregulation of the AKT/mTOR pathway [44].